Assenagon Asset Management’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-156
| Closed | -$14K | – | 1415 |
|
|
2022
Q3 | $14K | Sell |
156
-14,935
| -99% | -$1.34M | ﹤0.01% | 1272 |
|
|
2022
Q2 | $2.26M | Sell |
15,091
-12
| -0.1% | -$1.8K | 0.01% | 770 |
|
|
2022
Q1 | $3.66M | Sell |
15,103
-3,344
| -18% | -$811K | 0.01% | 589 |
|
|
2021
Q4 | $5.58M | Buy |
18,447
+14,419
| +358% | +$4.36M | 0.02% | 453 |
|
|
2021
Q3 | $1.67M | Buy |
4,028
+298
| +8% | +$123K | 0.01% | 720 |
|
|
2021
Q2 | $1.14M | Sell |
3,730
-6,397
| -63% | -$1.96M | ﹤0.01% | 854 |
|
|
2021
Q1 | $2.08M | Buy |
10,127
+1,603
| +19% | +$330K | 0.01% | 674 |
|
|
2020
Q4 | $1.71M | Buy |
8,524
+49
| +0.6% | +$9.8K | 0.01% | 533 |
|
|
2020
Q3 | $1.4M | Buy |
8,475
+2,131
| +34% | +$353K | 0.01% | 644 |
|
|
2020
Q2 | $1.57M | Buy |
+6,344
| New | +$1.57M | 0.01% | 646 |
|
|
2019
Q2 | – | Sell |
-5,097
| Closed | -$1.37M | – | 1155 |
|
|
2019
Q1 | $1.37M | Sell |
5,097
-4,522
| -47% | -$1.21M | 0.01% | 571 |
|
|
2018
Q4 | $2.05M | Buy |
9,619
+7,816
| +433% | +$1.66M | 0.02% | 397 |
|
|
2018
Q3 | $808K | Sell |
1,803
-500
| -22% | -$224K | 0.01% | 627 |
|
|
2018
Q2 | $934K | Buy |
+2,303
| New | +$934K | 0.01% | 345 |
|